Downregulation of HSP60 with HSP60 knockdown drives metabolic reprogramming in renal cell carcinoma, a process that promotes tumor progression and enhances mitochondria-dependent biosynthesis. The gene discussed is HSPD1; the disease is renal cell carcinoma.